BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vallet-Regí M, Schüth F, Lozano D, Colilla M, Manzano M. Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades? Chem Soc Rev 2022. [PMID: 35642539 DOI: 10.1039/d1cs00659b] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Singh N, Kim J, Kim J, Lee K, Zunbul Z, Lee I, Kim E, Chi S, Kim JS. Covalent organic framework nanomedicines: Biocompatibility for advanced nanocarriers and cancer theranostics applications. Bioactive Materials 2023;21:358-380. [DOI: 10.1016/j.bioactmat.2022.08.016] [Reference Citation Analysis]
2 Vallet-regí M, Colilla M, Izquierdo-barba I, Vitale-brovarone C, Fiorilli S. Achievements in Mesoporous Bioactive Glasses for Biomedical Applications. Pharmaceutics 2022;14:2636. [DOI: 10.3390/pharmaceutics14122636] [Reference Citation Analysis]
3 Sánchez-salcedo S, García A, González-jiménez A, Vallet-regí M. Antibacterial effect of 3D printed mesoporous bioactive glass scaffolds doped with metallic silver nanoparticles. Acta Biomaterialia 2022. [DOI: 10.1016/j.actbio.2022.10.045] [Reference Citation Analysis]
4 Wang Z, Yu Y, Wang C, Li J, Pang Y. Advances in the Application of Nanomaterials to the Treatment of Melanoma. Pharmaceutics 2022;14. [PMID: 36297527 DOI: 10.3390/pharmaceutics14102090] [Reference Citation Analysis]
5 Yang G, Liu Y, Ding L, Tao F, Zhu M, Shi Z, Wen J, Niu M, Li X, Xu Z, Qin W, Fei C, Chen J. A state-of-the-art review on LSD1 and its inhibitors in breast cancer: Molecular mechanisms and therapeutic significance. Front Pharmacol 2022;13:989575. [DOI: 10.3389/fphar.2022.989575] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Kong J, Park SS, Ha C. pH-Sensitive Polyacrylic Acid-Gated Mesoporous Silica Nanocarrier Incorporated with Calcium Ions for Controlled Drug Release. Materials 2022;15:5926. [DOI: 10.3390/ma15175926] [Reference Citation Analysis]
7 Wu H, Wang M, Zhu J, Li Z, Wang W, Gu L, Shen F, Yang T. Mesoporous Nanoparticles for Diagnosis and Treatment of Liver Cancer in the Era of Precise Medicine. Pharmaceutics 2022;14:1760. [DOI: 10.3390/pharmaceutics14091760] [Reference Citation Analysis]
8 Ribeiro TC, Sábio RM, Carvalho GC, Fonseca-santos B, Chorilli M. Exploiting Mesoporous Silica, Silver And Gold Nanoparticles For Neurodegenerative Diseases Treatment. International Journal of Pharmaceutics 2022. [DOI: 10.1016/j.ijpharm.2022.121978] [Reference Citation Analysis]
9 Katir N, El Haskouri J, Amoros P, El Kadib A. Cooperative assembly of redistributed arylgermanium-bearing alkoxysilanes in a mesostructured siloxane network. New J Chem . [DOI: 10.1039/d2nj02868a] [Reference Citation Analysis]
10 Shaffer CC, Zhai C, Chasteen JL, Orlova T, Zhukovskyi M, Smith BD. Silica nanoparticle remodeling under mild conditions: versatile one step conversion of mesoporous to hollow nanoparticles with simultaneous payload loading. Nanoscale 2022. [DOI: 10.1039/d2nr05528g] [Reference Citation Analysis]